Granocyte-13


What it is used for

To reduce the duration of neutropenia and the severity of infections in patients with non-myeloid malignancy who have either undergone autologous or allogeneic bone marrow transplantation or undergone treatment with established cytotoxic chemotherapy. To reduce the incidence of infection associated with established cytotoxic chemotherapy. To mobilise peripheral blood progenitor cells (PBPCs) either with Granocyte alone, or after myelosuppresive chemotherapy, in order to accelerate haematopoietic recovery by infusion of such cells, after myelosuppressive or myeloablative therapy in patients with non-myeloid malignancies. Granocyte is also indicated to accelerate the engraftment of these cells after their infusion. To mobilise peripheral blood progenitor cells (PBPCs) in healthy donors. In the treatment of severe congenital neutropenia.


How to take it

The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.

  • Store below 30 degrees Celsius
  • Do Not use if Colour Changes
  • Shelf lifetime is 30 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems


How to take it

The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.

  • Store below 30 degrees Celsius
  • Do Not use if Colour Changes
  • Shelf lifetime is 30 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Pregnant or planning a pregnancy?

For the active ingredient lenograstim

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.


Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.


Visual appearance

White cake (lyophilised powder) in a glass vial with rubber stoppers and flip off cap


Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

0 0 votes
Do you use this medicine? Rate it:
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments